[ad_1] Pfizer Inc. will charge $1,390 for a five-day course of its Paxlovid COVID-19 antiviral…
-
-
[ad_1] An antiviral drug that was granted an emergency use authorization by the U.S. Food…
-
[ad_1] In the latest sign that the coronavirus pandemic is not yet over, the World…
-
[ad_1] Pfizer PFE, +0.10% put out its yearly sales guidance for Comirnaty, the COVID-19 vaccine…
-
[ad_1] China’s health service on Friday approved an antiviral to treat COVID-19 as one health…
-
[ad_1] TOKYO—Japan approved an antiviral pill from Shionogi & Co. to treat Covid-19 after the…
-
[ad_1] Gilead Sciences Inc. GILD, -0.29% has steadily expanded the use of Veklury while much…
